share_log
Reuters ·  Jun 27 16:07
Acasti Pharma Inc: Anticipate Staying on Track for a Potential Nda Submission to FDA in First Half of Calendar 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment